Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Stephanie L, Pugh"'
Autor:
Christopher D. Abraham, MD, Stephanie L. Pugh, PhD, Joseph A. Bovi, MD, Vinai Gondi, MD, Minesh P. Mehta, MD, Tammie Benzinger, MD, Christopher J. Owen, MS, Simon S. Lo, MD, Vijayananda Kundapur, MD, Paul D. Brown, MD, Alexander Y. Sun, MD, Steven P. Howard, MD, Albert S. DeNittis, MD, Clifford G. Robinson, MD, Lisa A. Kachnic, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 6, Pp 100859- (2022)
Purpose: Hippocampal volume (HV) is an established predicting factor for neurocognitive function (NCF) in neurodegenerative disease. Whether the same phenomenon exists with hippocampal-avoidant whole brain radiation therapy is not known; therefore, w
Externí odkaz:
https://doaj.org/article/1121ee18ee694870924f5da0d3619b23
Autor:
Joseph A. Bovi, MD, Stephanie L. Pugh, PhD, David Sabsevitz, PhD, Clifford G. Robinson, MD, Eric Paulson, PhD, Minesh P. Mehta, MD, Vinai Gondi, MD, Vijayananda Kundapur, MD, Mark S. Shahin, MD, Samuel T. Chao, MD, Mitch Machtay, MD, Albert S. DeNittis, MD, Nadia N. Laack, MD, Jeffrey N. Greenspoon, MD, Kathleen N. Moore, MD, Jiayi Huang, MD, Michael M. Dominello, DO, Lisa A. Kachnic, MD
Publikováno v:
Advances in Radiation Oncology, Vol 4, Iss 4, Pp 579-586 (2019)
Purpose: NRG Oncology's RTOG 0933 demonstrated benefits to memory preservation after hippocampal avoidant whole-brain radiation therapy (HA-WBRT), the avoidance of radiation dose to the hippocampus (using intensity modulated radiation planning and de
Externí odkaz:
https://doaj.org/article/c9662f62dac04e8fb0122e9415a29190
Autor:
Jinbing Bai, Stephanie L. Pugh, Ronald Eldridge, Katherine A. Yeager, Qi Zhang, W. Robert Lee, Amit B. Shah, Ian S. Dayes, David P. D'Souza, Jeff M. Michalski, Jason A. Efstathiou, John M. Longo, Thomas M. Pisansky, Jordan M. Maier, Sergio L. Faria, Anand B. Desai, Samantha A. Seaward, Howard M. Sandler, Mary E. Cooley, Deborah W. Bruner
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 116:39-49
Autor:
Rahul Khairnar, Stephanie L Pugh, Howard M Sandler, W Robert Lee, Ester Villalonga Olives, C Daniel Mullins, Francis B Palumbo, Deborah W Bruner, Fadia T Shaya, Soren M Bentzen, Amit B Shah, Shawn C Malone, Jeff M Michalski, Ian S Dayes, Samantha A Seaward, Michele Albert, Adam D Currey, Thomas M Pisansky, Yuhchyau Chen, Eric M Horwitz, Albert S DeNittis, Felix Y Feng, Mark V Mishra
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0249123 (2021)
PurposeThe Expanded Prostate Cancer Index Composite (EPIC) is the most commonly used patient reported outcome (PRO) tool in prostate cancer (PC) clinical trials, but health utilities associated with the different health states assessed with this tool
Externí odkaz:
https://doaj.org/article/28c81274f9f04bb1953d4d523b5584d0
Autor:
Canhua Xiao, PhD, Jennifer Moughan, MS, Benjamin Movsas, MD, Andre A. Konski, MD, Gerald E. Hanks, MD, James D. Cox, MD, Mack Roach, III, MD, Kenneth L. Zeitzer, MD, Colleen A. Lawton, MD, Christopher A. Peters, MD, Seth A. Rosenthal, MD, I.-Chow Joe Hsu, MD, Eric M. Horwitz, MD, Mark V. Mishra, MD, Jeff M. Michalski, MD, Matthew B. Parliament, MD, David P. D'Souza, MD, Stephanie L. Pugh, PhD, Deborah W. Bruner, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 3, Iss 3, Pp 405-411 (2018)
Purpose: A meta-analysis of sociodemographic variables and their association with late (>180 days from start of radiation therapy[RT]) bowel, bladder, and clustered bowel and bladder toxicities was conducted in patients with high-risk (clinical stage
Externí odkaz:
https://doaj.org/article/6ff723a9aa3647fc883ffb1eee1dce8a
Autor:
Anamaria R. Yeung, Snehal Deshmukh, Ann H. Klopp, Karen M. Gil, Lari Wenzel, Shannon N. Westin, Andre A. Konski, David K. Gaffney, William Small, J. Spencer Thompson, Desiree E. Doncals, Guilherme H.C. Cantuaria, David P. D'Souza, Amy Chang, Vijayananda Kundapur, Dasarahally S. Mohan, Michael L. Haas, Yong Bae Kim, Catherine L. Ferguson, Stephanie L. Pugh, Lisa A. Kachnic, Deborah W. Bruner
Publikováno v:
Journal of Clinical Oncology. 40:3115-3119
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned coprimary or secondary analyses are not yet available. Clinical Tri
Autor:
Andrew B Lassman, Stephanie L Pugh, Tony J C Wang, Kenneth Aldape, Hui K Gan, Matthias Preusser, Michael A Vogelbaum, Erik P Sulman, Minhee Won, Peixin Zhang, Golnaz Moazami, Marian S Macsai, Mark R Gilbert, Earle E Bain, Vincent Blot, Peter J Ansell, Suvajit Samanta, Madan G Kundu, Terri S Armstrong, Jeffrey S Wefel, Clemens Seidel, Filip Y de Vos, Sigmund Hsu, Andrés F Cardona, Giuseppe Lombardi, Dmitry Bentsion, Richard A Peterson, Craig Gedye, Véronique Bourg, Antje Wick, Walter J Curran, Minesh P Mehta
Publikováno v:
Neuro-Oncology. 25:339-350
Background Approximately 50% of newly diagnosed glioblastomas (GBMs) harbor epidermal growth factor receptor gene amplification (EGFR-amp). Preclinical and early-phase clinical data suggested efficacy of depatuxizumab mafodotin (depatux-m), an antibo
Autor:
Samuel Ryu, Snehal Deshmukh, Robert D. Timmerman, Benjamin Movsas, Peter Gerszten, Fang-Fang Yin, Adam Dicker, Christopher D. Abraham, Jim Zhong, Stephen L. Shiao, Richard Tuli, Anand Desai, Loren K. Mell, Puneeth Iyengar, Ying J. Hitchcock, Aaron Max Allen, Steven Burton, Doris Brown, Hadley J. Sharp, Neal E. Dunlap, M. Salim Siddiqui, Timothy H. Chen, Stephanie L. Pugh, Lisa A. Kachnic
Publikováno v:
JAMA Oncology.
ImportanceSpine metastasis can be treated with high-dose radiation therapy with advanced delivery technology for long-term tumor and pain control.ObjectiveTo assess whether patient-reported pain relief was improved with stereotactic radiosurgery (SRS
Autor:
C Leland Rogers, Stephanie L Pugh, Michael A Vogelbaum, Arie Perry, Lynn S Ashby, Jignesh M Modi, Anthony M Alleman, Igor J Barani, Steve Braunstein, Joseph A Bovi, John F de Groot, Anthony C Whitton, Scott M Lindhorst, Nimisha Deb, Dennis C Shrieve, Hui-Kuo Shu, Beatrice Bloom, Mitchell Machtay, Mark V Mishra, Clifford G Robinson, Minhee Won, Minesh P Mehta
Publikováno v:
Neuro Oncol
Background Three- and five-year progression-free survival (PFS) for low-risk meningioma managed with surgery and observation reportedly exceeds 90%. Herewith we summarize outcomes for low-risk meningioma patients enrolled on NRG/RTOG 0539. Methods Th
Autor:
Christina I. Tsien, Stephanie L. Pugh, Adam P. Dicker, Jeffrey J. Raizer, Martha M. Matuszak, Enrico C. Lallana, Jiayi Huang, Ozer Algan, Nimisha Deb, Lorraine Portelance, John L. Villano, John T. Hamm, Kevin S. Oh, Arif N. Ali, Michelle M. Kim, Scott M. Lindhorst, Minesh P. Mehta
PURPOSE To assess whether reirradiation (re-RT) and concurrent bevacizumab (BEV) improve overall survival (OS) and/or progression-free survival (PFS), compared with BEV alone in recurrent glioblastoma (GBM). The primary objective was OS, and secondar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a4c03b0f137d718334db45ae38b7cb4
https://www.zora.uzh.ch/id/eprint/228975/
https://www.zora.uzh.ch/id/eprint/228975/